{"id":6016,"date":"2022-03-17T17:40:00","date_gmt":"2022-03-17T17:40:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/"},"modified":"2022-03-17T17:40:00","modified_gmt":"2022-03-17T17:40:00","slug":"positiv-utveckling-i-nanexas-patentintrangsarende","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/","title":{"rendered":"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende"},"content":{"rendered":"
\n

Nanexa AB meddelar idag att en amerikansk domstol (United States District Court for the District of Delaware), i m\u00e5let mellan Nanexa och Vitrivax, Inc, idag avslagit Vitrivax beg\u00e4ran om att avvisa Nanexas k\u00e4rom\u00e5l avseende patentintr\u00e5ng. Domstolen har vidare avslagit Vitrivax yrkande om att skyldigheten att l\u00e4mna ut information (s k discovery) ska upph\u00f6ra. Nanexas yrkande om att discovery-processen ska tvingas forts\u00e4tta var ocks\u00e5 framg\u00e5ngsrik. Nanexa kommer forts\u00e4tta att aktivt skydda sina v\u00e4rdefulla immateriella r\u00e4ttigheter h\u00e4nf\u00f6rliga till sitt drug delivery-system PharmaShell\u00ae.<\/strong><\/p>\n<\/div>\n

\n<\/div>\n
\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar parenterala l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n\n

Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa AB meddelar idag att en amerikansk domstol (United States District Court for the District of Delaware), i m\u00e5let mellan Nanexa och Vitrivax, Inc, idag avslagit Vitrivax beg\u00e4ran om att avvisa Nanexas k\u00e4rom\u00e5l avseende patentintr\u00e5ng. Domstolen har vidare avslagit Vitrivax yrkande om att skyldigheten att l\u00e4mna ut information (s k discovery) ska upph\u00f6ra. Nanexas yrkande om att discovery-processen ska tvingas forts\u00e4tta var ocks\u00e5 framg\u00e5ngsrik. Nanexa kommer forts\u00e4tta att aktivt skydda sina v\u00e4rdefulla immateriella r\u00e4ttigheter h\u00e4nf\u00f6rliga till sitt drug delivery-system PharmaShell\u00ae.<\/p>\n","protected":false},"template":"","class_list":["post-6016","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nPositiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB meddelar idag att en amerikansk domstol (United States District Court for the District of Delaware), i m\u00e5let mellan Nanexa och Vitrivax, Inc, idag avslagit Vitrivax beg\u00e4ran om att avvisa Nanexas k\u00e4rom\u00e5l avseende patentintr\u00e5ng. Domstolen har vidare avslagit Vitrivax yrkande om att skyldigheten att l\u00e4mna ut information (s k discovery) ska upph\u00f6ra. Nanexas yrkande om att discovery-processen ska tvingas forts\u00e4tta var ocks\u00e5 framg\u00e5ngsrik. Nanexa kommer forts\u00e4tta att aktivt skydda sina v\u00e4rdefulla immateriella r\u00e4ttigheter h\u00e4nf\u00f6rliga till sitt drug delivery-system PharmaShell\u00ae.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiv-utveckling-i-nanexas-patentintrangsarende\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiv-utveckling-i-nanexas-patentintrangsarende\\\/\",\"name\":\"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2022-03-17T17:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiv-utveckling-i-nanexas-patentintrangsarende\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiv-utveckling-i-nanexas-patentintrangsarende\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiv-utveckling-i-nanexas-patentintrangsarende\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/","og_locale":"sv_SE","og_type":"article","og_title":"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende - Nanexa AB","og_description":"Nanexa AB meddelar idag att en amerikansk domstol (United States District Court for the District of Delaware), i m\u00e5let mellan Nanexa och Vitrivax, Inc, idag avslagit Vitrivax beg\u00e4ran om att avvisa Nanexas k\u00e4rom\u00e5l avseende patentintr\u00e5ng. Domstolen har vidare avslagit Vitrivax yrkande om att skyldigheten att l\u00e4mna ut information (s k discovery) ska upph\u00f6ra. Nanexas yrkande om att discovery-processen ska tvingas forts\u00e4tta var ocks\u00e5 framg\u00e5ngsrik. Nanexa kommer forts\u00e4tta att aktivt skydda sina v\u00e4rdefulla immateriella r\u00e4ttigheter h\u00e4nf\u00f6rliga till sitt drug delivery-system PharmaShell\u00ae.","og_url":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/","url":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/","name":"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2022-03-17T17:40:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/positiv-utveckling-i-nanexas-patentintrangsarende\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Positiv utveckling i Nanexas patentintr\u00e5ngs\u00e4rende"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/6016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=6016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}